» Articles » PMID: 38291221

Establishment of a Synchronized Tyrosinase Transport System Revealed a Role of Tyrp1 in Efficient Melanogenesis by Promoting Tyrosinase Targeting to Melanosomes

Overview
Journal Sci Rep
Specialty Science
Date 2024 Jan 30
PMID 38291221
Authors
Affiliations
Soon will be listed here.
Abstract

Tyrosinase (Tyr) is a key enzyme in the process of melanin synthesis that occurs exclusively within specialized organelles called melanosomes in melanocytes. Tyr is synthesized and post-translationally modified independently of the formation of melanosome precursors and then transported to immature melanosomes by a series of membrane trafficking events that includes endoplasmic reticulum (ER)-to-Golgi transport, post-Golgi trafficking, and endosomal transport. Although several important regulators of Tyr transport have been identified, their precise role in each Tyr transport event is not fully understood, because Tyr is present in several melanocyte organelles under steady-state conditions, thereby precluding the possibility of determining where Tyr is being transported at any given moment. In this study, we established a novel synchronized Tyr transport system in Tyr-knockout B16-F1 cells by using Tyr tagged with an artificial oligomerization domain FM4 (named Tyr-EGFP-FM4). Tyr-EGFP-FM4 was initially trapped at the ER under oligomerized conditions, but at 30 min after chemical dissociation into monomers, it was transported to the Golgi and at 9 h reached immature melanosomes. Melanin was then detected at 12 h after the ER exit of Tyr-EGFP-FM4. By using this synchronized Tyr transport system, we were able to demonstrate that Tyr-related protein 1 (Tyrp1), another melanogenic enzyme, is a positive regulator of efficient Tyr targeting to immature melanosomes. Thus, the synchronized Tyr transport system should serve as a useful tool for analyzing the molecular mechanism of each Tyr transport event in melanocytes as well as in the search for new drugs or cosmetics that artificially regulate Tyr transport.

Citing Articles

Drug Repurposing of Voglibose, a Diabetes Medication for Skin Health.

Kim H, Hyun C Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006038 PMC: 11859330. DOI: 10.3390/ph18020224.

References
1.
Ohishi Y, Kinoshita R, Marubashi S, Ishida M, Fukuda M . The BLOC-3 subunit HPS4 is required for activation of Rab32/38 GTPases in melanogenesis, but its Rab9 activity is dispensable for melanogenesis. J Biol Chem. 2019; 294(17):6912-6922. PMC: 6497944. DOI: 10.1074/jbc.RA119.007345. View

2.
Jimenez-Cervantes C, Martinez-Esparza M, Solano F, Lozano J, Garcia-Borron J . Molecular interactions within the melanogenic complex: formation of heterodimers of tyrosinase and TRP1 from B16 mouse melanoma. Biochem Biophys Res Commun. 1999; 253(3):761-7. DOI: 10.1006/bbrc.1998.9817. View

3.
Raposo G, Marks M . Melanosomes--dark organelles enlighten endosomal membrane transport. Nat Rev Mol Cell Biol. 2007; 8(10):786-97. PMC: 2786984. DOI: 10.1038/nrm2258. View

4.
Dennis M, Delevoye C, Acosta-Ruiz A, Hurbain I, Romao M, Hesketh G . BLOC-1 and BLOC-3 regulate VAMP7 cycling to and from melanosomes via distinct tubular transport carriers. J Cell Biol. 2016; 214(3):293-308. PMC: 4970331. DOI: 10.1083/jcb.201605090. View

5.
Kobayashi T, Urabe K, Winder A, Tsukamoto K, Brewington T, Imokawa G . DHICA oxidase activity of TRP1 and interactions with other melanogenic enzymes. Pigment Cell Res. 1994; 7(4):227-34. DOI: 10.1111/j.1600-0749.1994.tb00054.x. View